Literature DB >> 17223016

Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.

A Panagiotakopoulou, G L Daikos, V Miriagou, A Loli, E Tzelepi, L S Tzouvelekis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17223016     DOI： 10.1016/j.ijantimicag.2006.11.004

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  4 in total

1.  Does the activity of the combination of imipenem and colistin in vitro exceed the problem of resistance in metallo-beta-lactamase-producing Klebsiella pneumoniae isolates?

Authors:  Maria Souli; Panagiota Danai Rekatsina; Zoi Chryssouli; Irene Galani; Helen Giamarellou; Kyriaki Kanellakopoulou
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

Review 2.  Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.

Authors:  Jesús Rodríguez-Baño; Belén Gutiérrez-Gutiérrez; Isabel Machuca; Alvaro Pascual
Journal:  Clin Microbiol Rev       Date:  2018-02-14       Impact factor: 26.132

Review 3.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

4.  Carbapenem-resistant Enterobacter cloacae and the emergence of metallo-beta-lactamase-producing strains in a third-level hospital (Santiago de Compostela, NW Spain).

Authors:  M Treviño; L Moldes; L Martínez-Lamas; C Varón; B J Regueiro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-06-06       Impact factor: 3.267
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.